MedPath

The effect of folic acid on complications of endometrial hyperplasia patients

Phase 3
Conditions
endometrial hyperplasia.
endometrial hyperplasia
E11.2
Registration Number
IRCT2016060122562N2
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Aged 35 to 55 years
Patients with endometrial hyperplasia

Exclusion Criteria

Smoking
Unwilling to cooperate
Menopausal women
History of cardiovascular disease
Diabetes mellitus
Hypertension
Untreated thyroid disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Regression. Timepoint: Before and three months after intervention. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath